A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity-score weighted multicenter approach. https://t.co/1ugDWF2mqT https://t.co/Ihw0Zv9JYN
27 followers
1 followers
RT @Myeloma_Doc: Biosimilar filgrastim + #Mozobil works well for stem cell mobilization in #myeloma & #lymphoma pts: https://t.co/VSlYrAFpP…
6,983 followers
RT @Myeloma_Doc: Biosimilar filgrastim + #Mozobil works well for stem cell mobilization in #myeloma & #lymphoma pts: https://t.co/VSlYrAFpP…
14,844 followers
Biosimilar filgrastim + #Mozobil works well for stem cell mobilization in #myeloma & #lymphoma pts: https://t.co/VSlYrAFpPq. https://t.co/YTOtn6t9hn